| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of ruxolitinib and decitabine to modified busulfan/cyclophosphamide conditioning regimen for prophylaxis relapse in high-risk acute myeloid leukemia: the phase 2 prospective study
|
Wei, Yujun
|
|
|
103 |
11 |
p. 4707-4719
|
artikel
|
| 2 |
Alectinib maintenance therapy following cord blood transplantation for relapsed pediatric anaplastic large cell lymphoma with central nervous system involvement
|
Tamefusa, Kosuke
|
|
|
103 |
11 |
p. 4805-4809
|
artikel
|
| 3 |
Allogeneic amnion transplantation for the management of cutaneous graft-versus-host disease with associated ulcers: A promising therapeutic strategy
|
Siegmund, Andreas
|
|
|
103 |
11 |
p. 4783-4787
|
artikel
|
| 4 |
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma
|
Christofyllakis, Konstantinos
|
|
|
103 |
11 |
p. 4599-4606
|
artikel
|
| 5 |
A novel FNDC3B::MECOM fusion gene accompanied with Der(5; 17)(p10; q10) in acute myelocytic leukemia
|
Su, Zhan
|
|
|
103 |
11 |
p. 4823-4825
|
artikel
|
| 6 |
Antileukaemic rescue by dose-dense donor-lymphocyte infusions in T-PLL after allogeneic stem cell transplantation – a case report
|
Späth, Christian
|
|
|
103 |
11 |
p. 4777-4778
|
artikel
|
| 7 |
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma
|
Goldsmith, Scott R.
|
|
|
103 |
11 |
p. 4557-4565
|
artikel
|
| 8 |
Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate
|
De Santis, Maria
|
|
|
103 |
11 |
p. 4789-4791
|
artikel
|
| 9 |
A rare case of glanzmann thrombasthenia with concomitant factor VII deficiency
|
Zohair, Muhammad
|
|
|
103 |
11 |
p. 4779-4781
|
artikel
|
| 10 |
Aspergillus calidoustus and Talaromyces columbinus infections in chronic graft-versus-host disease
|
Pacini, Emanuele
|
|
|
103 |
11 |
p. 4797-4800
|
artikel
|
| 11 |
Assessment of the clinical and laboratory risk factors for thrombosis in neonates admitted to neonatal intensive care unit (two Egyptian tertiary centers experience)
|
Abdelsamei, Ebtihal Mokhtar
|
|
|
103 |
11 |
p. 4749-4757
|
artikel
|
| 12 |
A systematic review and meta-analysis of the morbidity of efficacy endpoints and bleeding events in elderly and young patients treated with the same dose rivaroxaban
|
Ren, Jianwei
|
|
|
103 |
11 |
p. 4363-4373
|
artikel
|
| 13 |
Baseline platelet count and long-term clinical outcomes in patients with acute venous thromboembolism: a prospective cohort study
|
Stuby, Johann
|
|
|
103 |
11 |
p. 4721-4729
|
artikel
|
| 14 |
CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase
|
Kramp, Laura-Jane
|
|
|
103 |
11 |
p. 4811-4815
|
artikel
|
| 15 |
Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis
|
Bai, Si-Jun
|
|
|
103 |
11 |
p. 4649-4660
|
artikel
|
| 16 |
Correction to: Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021
|
Kysenius, Kai
|
|
|
103 |
11 |
p. 4837
|
artikel
|
| 17 |
Correction to: Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study
|
Fu, Weijun
|
|
|
103 |
11 |
p. 4835-4836
|
artikel
|
| 18 |
Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype
|
Huang, Nanfang
|
|
|
103 |
11 |
p. 4485-4495
|
artikel
|
| 19 |
Early autologous and/or allogeneic stem cell transplantation for adult patients with advanced stage T- lymphoblastic leukemia/lymphoma or Burkitt lymphoma. A retrospective single-centre analysis
|
Steiner, N.
|
|
|
103 |
11 |
p. 4701-4705
|
artikel
|
| 20 |
Early prediction of platelet recovery with immature platelet fraction in patients receiving hematopoietic stem cell transplantation
|
Yang, Tsung-Han
|
|
|
103 |
11 |
p. 4661-4670
|
artikel
|
| 21 |
Enhancing end-of-life care: ethical considerations and the role of social work in geriatric bone marrow biopsy decisions
|
Guo, Shijie
|
|
|
103 |
11 |
p. 4821-4822
|
artikel
|
| 22 |
Fatal heart tamponade during induction treatment with azacitidine and venetoclax
|
Krecak, Ivan
|
|
|
103 |
11 |
p. 4827-4829
|
artikel
|
| 23 |
Impact of clinically unsuspected venous thrombotic events on CVC removal and survival in pediatric cancer patients: A population-based study from the Maritimes, Canada
|
MacDonald, Emma E.
|
|
|
103 |
11 |
p. 4741-4747
|
artikel
|
| 24 |
Increased trough concentration of venetoclax when combined with itraconazole for acute myeloid leukemia
|
Hagihara, Masao
|
|
|
103 |
11 |
p. 4497-4502
|
artikel
|
| 25 |
Initial US tertiary health care system experience using caplacizumab in patients with immune thrombotic thrombocytopenic purpura
|
Jones, Jennifer M.
|
|
|
103 |
11 |
p. 4449-4457
|
artikel
|
| 26 |
Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administration
|
Toenges, Rosa
|
|
|
103 |
11 |
p. 4687-4699
|
artikel
|
| 27 |
Investigation of infections status in pediatric patients with acute myeloid leukemia during the induction period–a retrospective study in two medical centers
|
Xu, Qingyuan
|
|
|
103 |
11 |
p. 4503-4510
|
artikel
|
| 28 |
Is radiotherapy still the optimal initial choice for patients with early-stage low-grade follicular lymphoma in the modern era? A population-based study
|
Zheng, Wenshuai
|
|
|
103 |
11 |
p. 4589-4598
|
artikel
|
| 29 |
Licochalcone A decreases cancer cell proliferation and enhances ferroptosis in acute myeloid leukemia through suppressing the IGF2BP3/MDM2 cascade
|
Han, Pingping
|
|
|
103 |
11 |
p. 4511-4524
|
artikel
|
| 30 |
Long-term complete remission in a patient with high-risk primary mediastinal B-cell lymphoma and iatrogenic symptomatic bradycardia after only two courses of DA-EPOCH-R followed by chemo-free treatment
|
Volzone, Francesco
|
|
|
103 |
11 |
p. 4759-4764
|
artikel
|
| 31 |
Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era
|
Donzelli, Livia
|
|
|
103 |
11 |
p. 4637-4642
|
artikel
|
| 32 |
Manifestations and outcomes of digestive tract involvement in adult Langerhans cell histiocytosis
|
Shang, Qing
|
|
|
103 |
11 |
p. 4459-4466
|
artikel
|
| 33 |
Measurable residual disease assessment prior to allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndromes: a 20-year monocentric study
|
Wery, Alexandre-Raphael
|
|
|
103 |
11 |
p. 4671-4685
|
artikel
|
| 34 |
Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia
|
Bader, Michael Stephan
|
|
|
103 |
11 |
p. 4831-4833
|
artikel
|
| 35 |
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms
|
Cvetković, Mirjana
|
|
|
103 |
11 |
p. 4545-4556
|
artikel
|
| 36 |
Olverembatinib treatment in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia
|
Zhu, Yiyan
|
|
|
103 |
11 |
p. 4643-4648
|
artikel
|
| 37 |
Only FLT3-ITD co-mutation did not have a deleterious effect on acute myeloid leukemia patients with NPM1 mutation, but concomitant with DNMT3A co-mutation or a < 3log reduction of MRD2 predicted poor survival
|
Duan, Wenbing
|
|
|
103 |
11 |
p. 4525-4535
|
artikel
|
| 38 |
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib
|
Pérez-Lamas, Lucía
|
|
|
103 |
11 |
p. 4537-4544
|
artikel
|
| 39 |
Predictive value of pre-treatment T lymphocyte subsets in patients with extranodal natural killer/T-cell lymphoma
|
Lu, Xingmei
|
|
|
103 |
11 |
p. 4621-4635
|
artikel
|
| 40 |
Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a meta-analysis and systematic review
|
Meng, Zilu
|
|
|
103 |
11 |
p. 4413-4425
|
artikel
|
| 41 |
Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia
|
Prajapati, Suresh Kumar
|
|
|
103 |
11 |
p. 4375-4400
|
artikel
|
| 42 |
Recent advances in CD5+ diffuse large B-cell lymphoma
|
Yue, Ningning
|
|
|
103 |
11 |
p. 4401-4412
|
artikel
|
| 43 |
Relapsed mantle cell lymphoma manifesting with soft tissue tumors of the extremities: University of Miami experience and review of the literature
|
Trutzer, Iris Margalit
|
|
|
103 |
11 |
p. 4581-4588
|
artikel
|
| 44 |
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome
|
Dias, Ajoy L.
|
|
|
103 |
11 |
p. 4427-4436
|
artikel
|
| 45 |
Rosai-Dorfman-Destombes disease in adults: a single center experience
|
Leung, Emily
|
|
|
103 |
11 |
p. 4467-4476
|
artikel
|
| 46 |
Safety of Rituximab biosimilar (Riximyo®) following a single switch from the reference product in patients with Non-Hodgkin’s lymphoma: a retrospective study
|
Song, Nina K
|
|
|
103 |
11 |
p. 4607-4612
|
artikel
|
| 47 |
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers
|
Laganà, Alessandro
|
|
|
103 |
11 |
p. 4731-4739
|
artikel
|
| 48 |
Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis
|
Pinczés, László Imre
|
|
|
103 |
11 |
p. 4817-4819
|
artikel
|
| 49 |
TGF-β: an active participant in the immune and metabolic microenvironment of multiple myeloma
|
Xue, Han-Yue
|
|
|
103 |
11 |
p. 4351-4362
|
artikel
|
| 50 |
The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia
|
Chen, Wen-ting
|
|
|
103 |
11 |
p. 4477-4483
|
artikel
|
| 51 |
Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis
|
Nunes, Rafael Amorim Belo
|
|
|
103 |
11 |
p. 4613-4620
|
artikel
|
| 52 |
Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait
|
Loh, Joanna B.
|
|
|
103 |
11 |
p. 4437-4447
|
artikel
|
| 53 |
Treatment patterns and burden of infection in patients with chronic lymphocytic leukemia and secondary immunodeficiency: a retrospective database study
|
Siffel, Csaba
|
|
|
103 |
11 |
p. 4567-4580
|
artikel
|
| 54 |
Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping
|
Klos, Corentine
|
|
|
103 |
11 |
p. 4793-4795
|
artikel
|
| 55 |
Vaginal involvement as a rare extranodal manifestation in advanced-stage follicular lymphoma: a case report and literature review
|
Chen, Hongyun
|
|
|
103 |
11 |
p. 4773-4776
|
artikel
|
| 56 |
Varying concentrations of tyrosine kinase inhibitors in chronic myeloid leukemia patients following bariatric surgery: a case series
|
Lau, Cedric
|
|
|
103 |
11 |
p. 4765-4771
|
artikel
|
| 57 |
15-year remission in refractory FLT3-mutated AML attained by sorafenib
|
Rummelt, Christoph
|
|
|
103 |
11 |
p. 4801-4803
|
artikel
|
Tijdschrift beschrijving